The protective effect of mushroom consumption on depressive symptoms in Korean population

[1]  L. Al-Shaar,et al.  Mushroom intake and depression: A population-based study using data from the US National Health and Nutrition Examination Survey (NHANES), 2005-2016. , 2021, Journal of affective disorders.

[2]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. , 2020, Diabetes care.

[3]  Emily P. Terlizzi,et al.  Symptoms of Depression Among Adults: United States, 2019. , 2020, NCHS data brief.

[4]  F. Giuliani,et al.  The Role of Inflammation in Depression and Fatigue , 2019, Front. Immunol..

[5]  F. Brandalise,et al.  Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers? , 2019, Evidence-based complementary and alternative medicine : eCAM.

[6]  D. Tousoulis,et al.  The Role of Inflammation , 2018 .

[7]  R. Beelman,et al.  Mushrooms: A rich source of the antioxidants ergothioneine and glutathione. , 2017, Food chemistry.

[8]  Bin Li,et al.  Dietary patterns and depression risk: A meta-analysis , 2017, Psychiatry Research.

[9]  A. Carvalho,et al.  Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies , 2017, Acta psychiatrica Scandinavica.

[10]  C. Mihalopoulos,et al.  A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial) , 2017, BMC Medicine.

[11]  Y. Shiao,et al.  Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice , 2016, Journal of Biomedical Science.

[12]  Jordi Alonso,et al.  Screening for Depression in the General Population with the Center for Epidemiologic Studies Depression (CES-D): A Systematic Review with Meta-Analysis , 2016, PloS one.

[13]  V. Sabaratnam,et al.  Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism , 2015, Critical reviews in biotechnology.

[14]  Peter Johansson,et al.  Depression and cardiovascular disease: a clinical review. , 2014, European heart journal.

[15]  A. Pillai,et al.  Antioxidants as potential therapeutics for neuropsychiatric disorders , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[16]  V. Fulgoni,et al.  Mushroom Intake is associated with Better Nutrient Intake and DietQuality: 2001-2010 National Health and Nutrition Examination Survey , 2013 .

[17]  Dik-Lung Ma,et al.  New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics , 2013, Evidence-based complementary and alternative medicine : eCAM.

[18]  Dan J Stein,et al.  Comparing the accuracy of brief versus long depression screening instruments which have been validated in low and middle income countries: a systematic review , 2012, BMC Psychiatry.

[19]  S. Saxena,et al.  Depression: a global public health concern , 2012 .

[20]  J. Simon,et al.  Anti-inflammatory activity of edible oyster mushroom is mediated through the inhibition of NF-κB and AP-1 signaling , 2011, Nutrition journal.

[21]  M. Marmot,et al.  Trajectories of Depressive Episodes and Hypertension Over 24 Years: The Whitehall II Prospective Cohort Study , 2011, Hypertension.

[22]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[23]  K. Ohnuki,et al.  Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. , 2010, Biomedical research.

[24]  K. Mori,et al.  Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double‐blind placebo‐controlled clinical trial , 2009, Phytotherapy research : PTR.

[25]  Y. Ahn,et al.  Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study , 2007, European Journal of Clinical Nutrition.

[26]  Nicoletta Pellegrini,et al.  A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[27]  P. Spinhoven,et al.  The criterion validity of the Center for Epidemiological Studies Depression Scale (CES‐D) in a sample of self‐referred elders with depressive symptomatology , 2004, International journal of geriatric psychiatry.

[28]  Omer Akyol,et al.  Antioxidant enzyme activities and oxidative stress in affective disorders , 2004, International clinical psychopharmacology.

[29]  Ji Eun Lee,et al.  Development of a Semi-quantitative Food Frequency Questionnaire Based on Dietary Data from the Korea National Health and Nutrition Examination Survey , 2003 .

[30]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[31]  M. Cho,et al.  Use of the Center for Epidemiologic Studies Depression (CES-D) Scale in Korea. , 1998, The Journal of nervous and mental disease.

[32]  P. Lewinsohn,et al.  Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. , 1997, Psychology and aging.

[33]  D. Ford,et al.  Depression and Risk for Onset of Type II Diabetes: A prospective population-based study , 1996, Diabetes Care.

[34]  S. Furukawa,et al.  Erinacines A, B, and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum , 1994 .

[35]  L. Radloff.  The CES-D Scale , 1977 .

[36]  L. Radloff.  The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .